Pay in 4 interest-free payments of $5.28 Learn more
Ships within 48 hours · Estimated delivery Oct 25 - Oct 30
Presented for research literature review only Yldrm AK et al
Be the first to rate this.
Potential molecular therapeutic targets based on the TME and breast cancer mechanism have been widely studied
NNMTi-treatment offers a promising therapeutic approach to address this unmet need 8,9,13
Researchers administered 15 mg/kg of GHK-Cu to aged (20-21 month) mice via two distinct paradigms: a short-term, 5-day intraperitoneal (IP) injection series, and a long-term, 8-week intranasal (IN) atomization protocol
US$ 24.05
US$ 28.83
US$ 24.23
US$ 27.57
